Abstract

1. In this study, cases of inoperable lung cancer coexistent with pulmonary tuberculosis were irradiated with cancerocidal doses. 2. Seven patients in whom neoplasm developed in an area of tuberculosis were treated. The dose of irradiation at the central lung varied from 4000 r to 6800 r given in 37 to 104 days. 3. All patients received antituberculosis drugs. 4. The total period of observation after irradiation varied from seven weeks to thirty-two and one-half months. 5. In only one of the seven patients was there x-ray film evidence of change that could possibly be due to relapse of tuberculosis. In this patient (Case 7) the changes might be due to radiation necrosis (8800 r). This patient, moreover, had discontinued antituberculosis drug treatment after irradiation. 6. The experience in this small series of patients would indicate that irradiation of pulmonary neoplasms coexistent with pulmonary tuberculosis with cancerocidal doses can be accomplished without danger of deterioration of the tuberculosis if proper antituberculosis drug coverage is provided. In the presence of considerable drug resistance it would be desirable to add another antituberculosis drug to which the microorganism is sensitive to avoid any possible hazard of irradiation.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.